Bextra Lawsuit Inquiry Form Blog Home Archives

|
: : : 2005-03-07 to 2005-03-13
Bextra Patients, painkillers, cardiovascular risks, substitutes - Monheit Law, lawsuits
March 8, 2005 08:51
As patients have turned to other painkillers to avoid the cardiovascular risks associated with Vioxx, Bextra and Celebrex, scientists are casting suspicion on several of the substitutes, especially Mobic.
Now that health concerns have been raised about newer anti-inflammatory drugs such as Vioxx, Celebrex and Bextra, some Americans may be taking another look at one of the few medicines that have been around since the Victorian era.
I heard on TV that Vioxx is coming back. Who did they pay off to make this happen? There is nothing to suggest a payoff and no one has decided that Vioxx is coming back yet. A panel of researchers at the Food and Drug Administration is thinking about it.
Ten members of the Food and Drug Administration advisory panel who voted that a group of powerful pain killers should continue to be sold had ties to the drug makers, a new analysis shows.
Who Do You Trust: FDA, Drugs, Doctors?
March 10, 2005 16:51
RedNova, Wed, 09 Mar 2005 7:15 AM PST
Some people were surprised last month when a panel of Food and Drug Administration advisers recommended that the pain medications Celebrex, Bextra and Vioxx be kept on the market. Although there are risks associated with the drugs, the experts said, they don't outweigh the benefits.
Consumer Drug Ads Facing Their Moment of Truth
March 11, 2005 16:48
RedNova, Fri, 11 Mar 2005 5:43 AM PST
Less show, more show-and-tell seen in wake of drug safety hearingsHealthDay News -- The landscape of prescription drug advertising to consumers will definitely change in the wake of recent government hearings on the popular painkillers Celebrex, Vioxx and Bextra.Exactly what the new panorama will look like is still unclear, but both industry and government officials predict consumers will be more
Majority abandon COX-2s, Spine-health poll shows
March 11, 2005 16:49
Datamonitor via Yahoo! UK & Ireland Finance, Thu, 10 Mar 2005 9:19 AM PST
Nearly two-thirds of patients who were taking a COX-2 inhibitor prior to the Vioxx recall and Celebrex/Bextra study findings have abandoned this class of pain medication, according to a new poll by peer-reviewed spine medicine portal, Spine-health.com.
Confused About Vioxx?
March 11, 2005 16:50
PR Newswire via Yahoo! Finance, Thu, 10 Mar 2005 11:25 AM PST DoctorSolve Suggests Questions to Ask Your Physician
If you suffer from arthritis, you've undoubtedly heard of Merck's blockbuster arthritis drug, Vioxx.
«
»
|